The conversation between human and AI assistant.
What are the major drug targets for leukemia?
Are there any specific inhibitors for these targets?
Yes, there are specific inhibitors for these targets such as imatinib, dasatinib and nilotinib which target BCR-ABL fusion protein in chronic myeloid leukemia.